Tempus AI (TEM) news
Recent news
CellCarta: Adds Tempus to CDX commercialization lab network as second commercial lab partner
CellCarta, a global contract research organization (CRO) laboratory serving the biopharmaceutical industry, has added Tempus as its second commercial laboratory partner in its Lab Network strategy for companion diagnostic (CDx) commercialization. This partnership follows CellCarta’s earlier…
AInvest Wire · Aug 6, 2026Tempus AI Inc shares fall 2% after the bell following results, outlook
AInvest Wire · Jul 30, 2026Tempus AI Inc Q2 adjusted EPS USD -0.04 vs. IBES estimate USD -0.14
Tempus AI Inc. (TEM) reported adjusted earnings per share (EPS) of -$0.04 for the second quarter of 2026, surpassing the IBES estimate of -$0.14 . This represents a significant improvement compared to the previous quarter, where the company recorded an adjusted loss of $0.13 per share, which was…
AInvest Wire · Jul 30, 2026Tempus AI shares down 6.4%
Tempus AI (NASDAQ: TEM) shares fell 6.4% in early trading on July 20, 2026, following the release of its second-quarter earnings report. The company reported revenue of $48.2 million, a 12% increase year-over-year but below the $51 million forecast by analysts [1]. The stock decline reflects…
AInvest Wire · Jul 20, 2026Personalis shares down 10% after Tempus AI to acquire co for $1.5 bln
Tempus AI Inc. will acquire Personalis in a $1.50 billion all-stock transaction structured as a 100% stock deal, with Personalis shareholders to receive $16.25 per share or an equivalent maximum exchange ratio of 0.3356 Tempus AI shares per Personalis share, marking the latest progress in…
AInvest Wire · Jul 20, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.